[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100435170":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Maryland, Baltimore","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"1.BMT Patients (Study)",null,"Patients prior to receiving a bone marrow transplant will be recruited during their initial intake prior to their BM transplant through the PI's regularly scheduled appointment with these patients.",[13],"Diagnostic Test: The standard care exam and biological specimens' collection",{"label":15,"type":10,"description":16,"interventionNames":17},"2.Controls","Patients with no history of eye disease or cancer history",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","The standard care exam and biological specimens' collection","During each visit, in addition to standard of care exams, certain biological specimens ( ocular surface wash, mucocellular material, corneal filaments or impression cytology of conjunctiva, blood or serum) will be collected.",[9,15],[25],{"name":26,"affiliation":5,"role":27},"Sarah Sunshine, MD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Sarah B Sunshine, MD","CONTACT","667-214-1292","ssunshine@som.umaryland.edu",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},"Patricia Lesho","410-328-2577","plesho@umm.edu",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Geenebaum Cancer Center, University of Maryland Medical Center","RECRUITING","Baltimore","Maryland","21201","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-76.61219,39.29038,{"lat":51,"lon":50},[54],{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100435170","2177gccciding-tx-targets-and-biomarkers-for-ocular-surface-disease-in-pt-w-ogvhd-100435170",false,"NCT04946721","2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w\u002F oGVHD","2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study","Inclusion Criteria:\n\n* Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits.\n* The patient must be able to understand and sign and date the informed consent form approved by the IRB.\n\nExclusion Criteria:\n\n* Vulnerable populations: neonates, children, prisoners, institutionalized individuals.\n* Inability or refusal to provide informed consent.\n* History of ocular surgery (except refractive surgery or cataract surgery)",true,"ALL","18 Years",{"count":68,"type":69},150,"ESTIMATED","OBSERVATIONAL","Evaluate and study the immunologic changes to the ocular surface in cancer patients.",[73,74],"Dry Eye Disease","oGVHD","2026-01-30",{"date":77,"type":78},"2026-02-03","ACTUAL",{"date":80,"type":78},"2022-04-27",{"date":82,"type":69},"2027-12-31",{"name":5,"class":6},1]